PHARMACEUTICAL COMBINATION BETWEEN A TRICYCLIC BETA-LACTAMASE INHIBITOR AND SPECIFIC BETA-LACTAMASE ANTIBIOTICS

MA50427AUndetermined Publication Date: 2021-05-12NOVARTIS AG

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: MA50427
Authority / Receiving Office: MA · MA
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2016-09-28
Filing Date: 2017-09-28
Publication Date: 2021-05-12

Application Information

Patent Timeline

28 Sep 2016

Priority

28 Sep 2017

Application

MA50427

12 May 2021

Publication

MA50427A

IPC: A61K31/407; A61K31/427; A61K31/431; A61K31/496; A61K31/546; A61K31/551; A61K45/06; A61P31/04; C07D471/18

CPC: A61P31/04; A61K45/06; A61K31/551; A61K31/5025; A61K31/407; A61K31/427; A61K31/431; A61K31/496

Inventors: CASAREZ Anthony; FUREGATI Markus

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Need to check novelty before this filing date? Find Prior Art

No text content released.